Field Trip Health Will Soon Provide Psychedelics To Veterans In Texas

Written By SykoActive

Clinics across the country are using ketamine for the treatment of mental health disorders like PTSD. Field Trip Health has opened a brand-new facility in Houston and is moving forward with ketamine therapies for veterans. Field Trip plans to provide MDMA-assisted psychotherapy to veterans with PTSD as soon as the FDA approves these psychedelic substances for therapeutic use. Field trip health expects the FDA will approve MDMA for the treatment of PTSD by 2023 and Psilocybin for depression by 2025. Texas Democrat, Alex Dominquez, authored a bill in the Texas House that would fund research on suicide and treatment-resistant PTSD in veterans, as well as a literature review of the existing studies on ketamine and MDMA's use and treatment of the disorder.

SykoActive

Graham Krutch, also known as 'Gram Kracker,' is the founder and CEO of SykoActive Non-Profit Association, boasting over two decades of experience in the industry of medicinal plants and psychedelic substances. His expertise extends from cultivation to patient consultation, primarily focusing on cannabis and psilocybin, alongside notable advancements in the hemp and CBD sector.

Under Graham's guidance, SykoActive investigates and advocates for the therapeutic uses of psychedelic plant medicines. He is committed to informing the public about secure alternative treatments and tackling the worldwide mental health dilemma.

Beyond his involvement in the psychedelic realm, Graham possesses a varied skill set in event marketing and product management. His efforts have been instrumental in the prosperity of leading convenience stores, and he shines in team leadership, strategic planning, and project management. As a fervent proponent of Applied AI Science and proficient in AI research and technological tools, he adeptly merges a customer-centric approach with an acute awareness of time constraints.

https://www.sykoactive.com
Previous

Harvard Law School Weighs In On Psychedelic Regulation
Next

Massachusetts Cities Are Decriminalizing Psychedelic Entheogens